Effectiveness of Information Technology Aided Relapse Prevention Program in Schizophrenia (ITAREPS)
Phase 2
- Conditions
- Schizophrenia
- Registration Number
- JPRN-UMIN000024304
- Lead Sponsor
- Chiba University Graduate School of Medicine
- Brief Summary
The risk of rehospitalization was reduced in the ITAREPS group compared with the control group (hazard ratio=0.21, number needed to treat (NNT)=4). The mean number of inpatient days was significantly lower in the ITAREPS group (18.5days) compared with the control group (88.8days) (p=0.036). The ratio of the number of rehospitalizations to that of relapses was significantly lower (p=0.035) and the mean change in total BPRS scores at relapse from baseline was significantly less in the ITAREPS group (p=0.019).
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Not provided
Exclusion Criteria
Having a history of other mental illnesses or complication Organic brain disease Serious physical illness Diagnosed by a doctor to be at risk of suicide at Providing informed consent
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method the number of rehospitalizations, the number of rehospitalization days, the number of relapse during the 12 months
- Secondary Outcome Measures
Name Time Method changes in the total Brief Psychiatric Rating Scale (BPRS) score at the time of rehospitalization and relapse after the start of the trial